1)Allolio B and Fassnacht M:Adrenocortical carcinoma:clinical update. J Clin Endocrinol Metab 91:2027-2037, 2006
2)Brix D, Allolio B, Fenske W, et al:Laparoscopic versus open adrenalectomy for adrenocortical carcinoma:surgical and oncologic outcome in 152 patients. Eur Urol 58:609-615, 2010
3)Schteingart DE:Conventional and novel strategies in the treatment of adrenocortical cancer. Braz J Med Biol Res 33:1197-1200, 2000
4)Berruti A, Terzolo M, Sperone P, et al:Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma:a large prospective phase II trial. Endocr Relat Cancer 12:657-666, 2005
5)Almeida MQ, Fragoso MC, Lotfi CF, et al:Expression of insulin-like growth factor-Ⅱ and its receptor in pediatric and adult adrenocortical tumors. J Clin Endocrinol Metab 93:3524-3531, 2008
6)Hong DS, Sebti SM, Newman RA, et al:Phase I trial of a combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in advanced malignancies. Clin Cancer Res 15:7061-7068, 2009
7)Lee JO, Lee KW, Kim CJ, et al:Metastatic adrenocortical carcinoma treated with sunitinib:a case report. Jpn J Clin Oncol 39:183-185, 2009
8)Sazawa A, Shinohara N, Harabayashi T, et al:Alternative approach in the treatment of adrenal metastasis with a real-time tracking radiotherapy in patients with hormone refractory prostate cancer. Int J Urol 16:410-412, 2009